20.73
price down icon31.01%   -9.32
after-market Dopo l'orario di chiusura: 21.00 0.27 +1.30%
loading

Apellis Pharmaceuticals Inc Borsa (APLS) Ultime notizie

pulisher
04:32 AM

Apellis Pharmaceuticals Inc (APLS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

04:32 AM
pulisher
02:41 AM

Apellis Pharma earnings beat by $0.12, revenue topped estimates - Investing.com Canada

02:41 AM
pulisher
01:07 AM

Apellis’ $458M Shocker: FDA Win, Analyst Buzz & 20% Stock Whiplash - ts2.tech

01:07 AM
pulisher
12:40 PM

Apellis (APLS) Shares Decline by Nearly 25% - GuruFocus

12:40 PM
pulisher
12:27 PM

How to build a dashboard for Apellis Pharmaceuticals Inc. stockBuy Signal & High Conviction Buy Zone Alerts - newser.com

12:27 PM
pulisher
10:54 AM

Earnings call transcript: Apellis Pharmaceuticals Q3 2025 earnings beat expectations but stock tumbles - Investing.com

10:54 AM
pulisher
10:41 AM

Apellis (APLS) Shares Drop Sharply by Over 19% - GuruFocus

10:41 AM
pulisher
10:30 AM

Apellis Gets A Rare Edge With Big Sobi Payout And Strong Drug Sales - Finimize

10:30 AM
pulisher
09:32 AM

Apellis Pharmaceuticals Inc reports results for the quarter ended September 30Earnings Summary - TradingView

09:32 AM
pulisher
09:30 AM

Apellis Pharmaceuticals (APLS) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

09:30 AM
pulisher
09:20 AM

Apellis Pharmaceuticals Swings to Q3 Earnings, Revenue Rises - MarketScreener

09:20 AM
pulisher
08:15 AM

Apellis Pharmaceuticals, Inc. (APLS) Q3 Earnings and Revenues Top Estimates - Yahoo Finance

08:15 AM
pulisher
07:52 AM

Earnings Flash (APLS) Apellis Pharmaceuticals Posts Q3 EPS $1.67, vs. FactSet Est of $1.60 - MarketScreener

07:52 AM
pulisher
07:44 AM

Apellis (APLS) Exceeds Q3 Revenue Expectations with Milestone Ac - GuruFocus

07:44 AM
pulisher
07:21 AM

Apellis Pharmaceuticals Reports Third Quarter 2025 Financial Results - The Manila Times

07:21 AM
pulisher
07:05 AM

Apellis (Nasdaq: APLS) receives $275M from Sobi royalty deal, revenue totals $459M - Stock Titan

07:05 AM
pulisher
06:43 AM

Will Apellis Pharmaceuticals Inc. stock maintain dividend yieldProfit Target & Fast Exit/Entry Strategy Plans - newser.com

06:43 AM
pulisher
05:29 AM

Apellis Pharmaceuticals Inc. recovery potential after sell off2025 Top Decliners & Safe Capital Growth Trade Ideas - newser.com

05:29 AM
pulisher
03:38 AM

Apellis Pharmaceuticals Inc. stock prediction for this weekTrade Ideas & Long-Term Investment Growth Plans - newser.com

03:38 AM
pulisher
03:35 AM

Published on: 2025-10-30 02:35:16 - newser.com

03:35 AM
pulisher
02:27 AM

Apellis signs royalty purchase deal with Sobi for Aspaveli - MSN

02:27 AM
pulisher
02:20 AM

Can Apellis Pharmaceuticals Inc. (1JK) stock survive global slowdownJuly 2025 Trends & Intraday High Probability Alerts - newser.com

02:20 AM
pulisher
Oct 29, 2025

Real time scanner hits for Apellis Pharmaceuticals Inc. explainedJuly 2025 Highlights & Reliable Breakout Forecasts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Would Apellis Pharmaceuticals (NASDAQ:APLS) Be Better Off With Less Debt? - 富途牛牛

Oct 29, 2025
pulisher
Oct 29, 2025

Earnings To Watch: Apellis Pharmaceuticals Inc (APLS) Reports Q3 2025 Result - Yahoo Finance

Oct 29, 2025
pulisher
Oct 29, 2025

Published on: 2025-10-29 02:11:34 - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Why retail investors favor Apellis Pharmaceuticals Inc. stock2025 EndofYear Setup & AI Enhanced Execution Alerts - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

How moving averages guide Apellis Pharmaceuticals Inc. tradingJuly 2025 Pullbacks & Capital Protection Trading Alerts - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Will a bounce in Apellis Pharmaceuticals Inc. offer an exitWeekly Gains Summary & Safe Entry Point Identification - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Is Apellis Pharmaceuticals Inc. stock attractive for income investorsEarnings Risk Report & Risk Managed Investment Entry Signals - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will breakout in Apellis Pharmaceuticals Inc. lead to full recoveryLong Setup & Detailed Earnings Play Alerts - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Regression analysis insights on Apellis Pharmaceuticals Inc. performancePortfolio Return Report & Entry and Exit Point Strategies - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Does Apellis Pharmaceuticals Inc. (1JK) stock trade below intrinsic valueQuarterly Performance Summary & Technical Entry and Exit Tips - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

What valuation ratios show for Apellis Pharmaceuticals Inc. (1JK) stockMarket Performance Recap & Advanced Technical Signal Analysis - newser.com

Oct 28, 2025
pulisher
Oct 28, 2025

Will Apellis Pharmaceuticals Inc. (1JK) stock rise with strong economyWeekly Gains Report & AI Powered Market Trend Analysis - newser.com

Oct 28, 2025
pulisher
Oct 27, 2025

What high frequency data says about Apellis Pharmaceuticals Inc.Market Risk Analysis & Consistent Return Strategy Ideas - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

How sentiment analysis helps forecast Apellis Pharmaceuticals Inc.Quarterly Profit Review & Step-by-Step Trade Execution Guides - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Can Apellis Pharmaceuticals Inc. stock sustain market leadership2025 Market Outlook & Weekly Breakout Watchlists - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

How Apellis Pharmaceuticals Inc. stock performs in weak economyMarket Growth Summary & Breakout Confirmation Alerts - newser.com

Oct 27, 2025
$36.94
price up icon 0.74%
$92.59
price up icon 2.67%
$28.67
price down icon 0.97%
$104.67
price up icon 1.28%
biotechnology ONC
$308.22
price down icon 2.11%
$194.22
price up icon 16.33%
Capitalizzazione:     |  Volume (24 ore):